|
Campaigns Goal Is to Reduce Morbidity and Mortality in U.S. Hospitals
ORLANDO, Fla., Dec. 16 /PRNewswire-FirstCall/ -- Baxter International Inc.
announced today the companys participation in the Institute for Healthcare
Improvements (IHI) 100,000 Lives Campaign through a $200,000 grant and a
commitment to further collaboration. Baxter, one of the Campaigns first
healthcare industry participants, pledged its support earlier this year, which
was announced this week during IHIs 17th Annual National Forum on Quality
Improvement in Health Care in Orlando, Fla.
"The 100,000 Lives Campaign has successfully rallied thousands of
hospitals together around a critical issue -- accelerating the pace of
improvement in U.S. hospital care," said Robert L. Parkinson, Jr., chairman
and chief executive officer of Baxter. "As a company thats been providing
innovative treatments for complex medical conditions to hospitals for over 70
years, we share the same passion for reducing medication errors and look
forward to supporting such an influential effort for the improvement of health
care in America."
"We appreciate Baxters generous support of the 100,000 Lives Campaign,"
said Don Berwick, M.D., president and chief executive officer of the Institute
for Healthcare Improvement. "The momentum the Campaign has built over the
last year wouldnt be possible without the commitment of hospitals and
companies such as Baxter, who share our vision of improving the health care
system through the adoption of consistent, proven interventions."
"Baxters commitment to the Campaign since nearly its inception has been
tremendous," said Joe McCannon, manager of the 100,000 Lives Campaign.
"Through Baxters support, we have been able to reach more people and increase
participation in this critical initiative."
More than 2,900 U.S. hospitals have joined the 100,000 Lives Campaign
since its inception last December. The Campaigns goal is to reduce morbidity
and mortality in U.S. hospitals, saving 100,000 lives over 18 months. This
aggressive goal will be achieved through the adoption of six clinical
interventions: creating rapid-response specialty teams; practicing evidence-
based care for heart attack patients; preventing adverse drug events by making
sure a patient is taking the appropriate drugs in the appropriate doses;
guarding against infections through a series of hygienic steps; preventing
surgical site infections; and protecting against ventilator-associated
pneumonia.
Baxter International Inc., through its subsidiaries, assists healthcare
professionals and their patients with treatment of complex medical conditions,
including cancer, hemophilia, immune disorders, kidney disease and trauma.
The company applies its expertise in medical devices, pharmaceuticals and
biotechnology to make a meaningful difference in patients lives.
|
|
